Parexel Introduces Discussions on Diversity Research
Parexel has announced the release of “Discussions on Diversity,” an in-depth research report and interactive microsite featuring patient, academic and physician voices highlighting the importance of diversity in clinical trials. The report, issued in conjunction with International Clinical Trials Day, represents a combination of qualitative and quantitative data reflecting perspectives from respondents around the world and identifies critical barriers to achieving diversity in clinical research.
The “Discussions on Diversity” report surveyed 1,945 respondents across a broad range of racial and ethnic groups in the United States, Canada, United Kingdom, Australia, France, Hungary, Italy, Mexico, Poland and Spain. Qualitative insights were gleaned from one-on-one interviews in the United Kingdom and United States and physician focus group sessions in the United States and Canada as well as Parexel’s Patient Advisory Council meetings in the United States, Italy, Australia and the United Kingdom.
To learn more, click here.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
